The authors reply

New England Journal of Medicine

Volumn 371, Issue 7, 2014, Pages 682-

  Schauer, Philip R ^a   Bhatt, Deepak L ^b   Kashyap, Sangeeta R ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BARIATRIC SURGERY; BLOOD PRESSURE; COST OF ILLNESS; DIABETES MELLITUS; DISEASE SEVERITY; GLYCEMIC CONTROL; KIDNEY DISEASE; LETTER; LIFESTYLE; MEDICAL CARE; MICROBIOME; OBESITY; PRIORITY JOURNAL; SURGICAL RISK; FEMALE; GASTRECTOMY; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; STOMACH BYPASS;

ANTIDIABETIC AGENT;

DIABETES MELLITUS, TYPE 2; FEMALE; GASTRECTOMY; GASTRIC BYPASS; HUMANS; HYPOGLYCEMIC AGENTS; MALE;

EID: 84906095269     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1407393     Document Type: Letter

References (5)

1. Roussel R, Travert F, Pasquet B, et al. Metformin use and mortality among patients with diabetes and atherothrombosis. Arch Intern Med 2010;170:1892-9.
2. Scirica BM, Bhatt DL, Braunwald E, et al. Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus. N Engl J Med 2013;369:1317-26.
3. Gerstein HC, Bosch J, Dagenais GR, et al. Basal insulin and cardiovascular and other outcomes in dysglycemia. N Engl J Med 2012;367:319-28.
4. Zhuo X, Zhang P, Hoerger TJ. Lifetime direct medical costs of treating type 2 diabetes and diabetic complications. Am J Prev Med 2013;45:253-61.
5. Chang SH, Stoll CR, Colditz GA. Cost-effectiveness of bariatric surgery: should it be universally available? Maturitas 2011;69:230-8.